Login to Your Account



PDL to Spin Off Biotech Assets into New Firm by End of Year

By Catherine Hollingsworth


Monday, April 14, 2008
Nearly a month after taking steps to streamline the company, PDL BioPharma Inc. said it plans to spin off its biotechnology assets into a separate publicly traded firm. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription